Segments - Diabetic Foot Care Market by Product (Footwear, Orthotics, and Wound Care Products), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global diabetic foot care market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of XX% during 2023–2031. The market is propelled by the increasing cases of diabetes due to unhealthy and sedentary lifestyles.
Diabetes damages the nerves and blood circulation in the feet, causing serious foot problems such as neuropathy, foot ulcers, and even necrosis. This causes major health concerns and requires severe measures such as limb amputation.
It has been estimated that approximately 1 out of 5 diabetic people visiting hospitals have diabetic foot problems. As a result, the demand for diabetic foot care products is increasing rapidly and is expected to boost the market during the forecast period.
According to the National Institutes of Health (NIH), people with diabetes have a 30 times greater risk of undergoing amputation, due to nerve problems and necrosis, than people without diabetes. This puts a significant economic strain on the healthcare system, with an annual value of around USD 4.3 billion in the United States.
The convenient lifestyle and modern technology are leading to an increasing prevalence of diabetes and obesity, due to the lack of physical activity, unhealthy eating habits, and insulin resistance. As per the studies, obese people are more likely to develop type 2 diabetes, which increases the chances of nerve damage and foot ulcers.
Diabetic foot care is an important part of limb preservation and is highly useful for patients, as it reduces the risk of nerve problems and other microvascular diseases.The most common diabetic foot care products include foot brushes, foot powder, lotion, Epsom salt, pumice stone, diabetic socks with moisturizing properties, callus shavers, and shoe pads.
The rise in awareness of diabetic foot care increased focus on the detection of any unnatural foot sensations and skin changes that lead to discomfort. As a result, diabetic people are proactively using such foot care products to prevent injury and infection.
The market report finds that the COVID-19 pandemic hindered the global diabetic foot care market, as the supply chain operations were slowed or completely cut, due to strict lockdowns and social distancing norms imposed by governments across the world to prevent the spread of the virus. This affected the availability of diabetic foot care products in the market.
However, with the normalization of the COVID-19 situation, the supply and distribution system is returning to its equilibrium. This is leading to increased availability of diabetic foot care products and is expected to have a positive impact on the overall growth of the market.
Rising prevalence of diabetes and obesity is anticipated to propel the market during the forecast period. The growing sedentary lifestyle is affecting overall health and hampers the functioning & sustainability of the human body. Numerous patients suffering from diabetes face the risk of neuropathy and necrosis cases that lead to limb amputations.
Diabetic foot care products provide comfort and convenience and reduce the risk of injury and infection. Furthermore, the use of foot therapy devices helps with pain management and improving the body’s agility.
As per the National Institutes of Health, around 150000 people in the US, undergo operation procedures for various types of lower extremity amputation every year. Problems such as diabetes, neuropathy, and peripheral vascular diseases are the most prominent causes of the increase in amputation procedures.
Increasing awareness regarding active diabetes management is expected to be a key factor in the growth of the global diabetic foot care market. Regular foot care and the use of foot care products are essential parts of diabetes management for patients.
This involves maintaining healthy skin and using the right kind of footwear that does not cause dry skin, cracks or sores, and change in the foot shape. It reduces the risk of diabetes complications and enhances the patient’s quality of life.
Lack of cost-effective quality foot care products is anticipated to impede the growth of the market. Most good quality foot care products are highly expensive, which makes them unaffordable for low- to mid-income consumers.
As a result, the expense prevents the widespread acceptance of diabetic foot care products. Increasing the affordability of such products without compromising quality can aid in overcoming such constraints and boost market growth.
Growing research and development for developing innovative foot care products is expected to provide significant growth opportunities to the market. There has been a rise in demand for highly effective diabetic foot care products.
This has increased the development of medical treatments, medicines, and wearable products that prevent infection, injury, and physical strain. For instance, the diabetic insoles for shoes are biomedically engineered to provide comfort and reduce pain by using a deep-heel cup and design for neutral posting.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Diabetic Foot Care Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Product (Footwear, Orthotics, and Wound Care Products) and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Thuasne; Orthofeet; New Balance; Gildan Activewear SR; medi USA; Essity Health & Medical; Biomedical Life Systems; HPMS, Inc.; PHC Holdings Corporation; and Aetrex Inc. |
Based on product, the diabetic foot care market is divided into footwear, orthotics, and wound care products. The wound care products segment is projected to hold the key share of the market during the projection period, as they facilitate fast healing of wounds and provide comfort to the patients. It helps in making them an essential part of diabetes patients’ daily care.
The wound care products include therapy devices such as foot orthotic insoles, antibiotic medication, and various types of wound care dressings, such as foam dressings, hydrocolloid dressings, film dressings, surgical dressings, hydrogel dressing, and Hydrofiber dressing. These are highly useful in diabetic foot ulcer treatment. The increasing prevalence of diabetes is likely to fuel the requirement for such products and is, therefore, expected to boost the market.
As per the American Diabetes Association (ADA), approximately 37.3 million people in the US (which is around 11.3% of the nation’s total population) had diabetes in 2019. Out of this, around 1.9 million Americans were diagnosed with type 1 diabetes, which includes 244,000 adolescents and children.
On the basis of distribution channel, the market is segregated into hospital pharmacies, online pharmacies, and retail pharmacies. The hospital pharmacies segment is anticipated to register a high CAGR, owing to the availability of treatment facilities and the presence of skilled and trained staff in the hospitals.
Most diabetic foot care medicines and therapy products are prescribed by doctors in hospitals. Therefore, it is highly convenient to purchase them from hospital pharmacies. As a result, the increasing prevalence of diabetes and obesity is expected to impel their growth.
The online pharmacies segment is expected to have considerable growth during the forecast period, due to the availability of all types of medical products at a cheaper price, with attractive offers and the convenience of home delivery.
The variety of diabetic foot care medicines and products available in online pharmacies makes it possible for patients to obtain these products even when it is not available in retail or hospital pharmacies.
Several major players in the online sector such as Amazon, have also entered the online pharmacy segment and are delivering medicines and medicinal products to customers based on doctor’s prescription. Ever since the pandemic, the trend of buying medicinal products online has increased considerably and is anticipated to grow with the expansion of supply and distribution networks.
In terms of region, the global diabetic foot care market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to the increasing diabetic population and unhealthy lifestyle choices.
The growing rate of obesity is a major concern, as it leads to major health problems including diabetes. Moreover, the region has a presence of several key market players and the availability of advanced healthcare analytics and infrastructure, which further boosts the growth of the market.
Asia Pacific is projected to have considerable growth in the global diabetic foot care market, due to factors such as the rising prevalence of diabetes & obesity, advancing healthcare management, and a rise in the geriatric population.
Diabetes pervasiveness in the region is leading to weaker immunity and insulin resistance, and the requirement of a rigorous healthcare regime. The rapid growth in healthcare infrastructure and increasing awareness about active diabetes management are expected to propel the market in the forecast period.
The diabetic foot care market has been segmented on the basis of
Key players competing in the global diabetic foot care market are Thuasne; Orthofeet; New Balance; Gildan Activewear; medi USA; Essity Health & Medical; Biomedical Life Systems; HPMS, Inc.; PHC Holdings Corporation; and Aetrex Inc.
These companies adopt numerous development strategies including collaboration, partnerships, product launches, mergers & acquisitions, and production expansion to expand their consumer base worldwide. These companies are using dynamic tactics to overcome constant obstacles such as fluctuating prices and competition from emerging local brands while continuously investing in research & development to maintain their growth. For instance,
In July 2022, the prominent US-based medical device distributor and manufacturer, medi USA, was nominated by the MAGNET GROUP (Mid-Atlantic Group Network of Shared Services) as an official seller for the GPO members. The diverse product portfolio of medi USA includes orthopedic bracing, medical compression therapy devices and garments, foot insoles, and wound care dressings, among others.